HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures.

Abstract
CYFIP2, encoding the evolutionary highly conserved cytoplasmic FMRP interacting protein 2, has previously been proposed as a candidate gene for intellectual disability and autism because of its important role linking FMRP-dependent transcription regulation and actin polymerization via the WAVE regulatory complex (WRC). Recently, de novo variants affecting the amino acid p.Arg87 of CYFIP2 were reported in four individuals with epileptic encephalopathy. We here report 12 independent patients harboring a variety of de novo variants in CYFIP2 broadening the molecular and clinical spectrum of a novel CYFIP2-related neurodevelopmental disorder. Using trio whole-exome or -genome sequencing, we identified 12 independent patients carrying a total of eight distinct de novo variants in CYFIP2 with a shared phenotype of intellectual disability, seizures, and muscular hypotonia. We detected seven different missense variants, of which two occurred recurrently (p.(Arg87Cys) and p.(Ile664Met)), and a splice donor variant in the last intron for which we showed exon skipping in the transcript. The latter is expected to escape nonsense-mediated mRNA decay resulting in a truncated protein. Despite the large spacing in the primary structure, the variants spatially cluster in the tertiary structure and are all predicted to weaken the interaction with WAVE1 or NCKAP1 of the actin polymerization regulating WRC-complex. Preliminary genotype-phenotype correlation indicates a profound phenotype in p.Arg87 substitutions and a more variable phenotype in other alterations. This study evidenced a variety of de novo variants in CYFIP2 as a novel cause of mostly severe intellectual disability with seizures and muscular hypotonia.
AuthorsMarkus Zweier, Anaïs Begemann, Kirsty McWalter, Megan T Cho, Lucia Abela, Siddharth Banka, Bettina Behring, Andrea Berger, Chester W Brown, Maryline Carneiro, Jiani Chen, Gregory M Cooper, Deciphering Developmental Disorders (DDD) Study, Candice R Finnila, Maria J Guillen Sacoto, Alex Henderson, Ulrike Hüffmeier, Pascal Joset, Bronwyn Kerr, Gaetan Lesca, Gloria S Leszinski, John Henry McDermott, Meira R Meltzer, Kristin G Monaghan, Roya Mostafavi, Katrin Õunap, Barbara Plecko, Zöe Powis, Gabriela Purcarin, Tiia Reimand, Korbinian M Riedhammer, John M Schreiber, Deepa Sirsi, Klaas J Wierenga, Monica H Wojcik, Sorina M Papuc, Katharina Steindl, Heinrich Sticht, Anita Rauch
JournalEuropean journal of human genetics : EJHG (Eur J Hum Genet) Vol. 27 Issue 5 Pg. 747-759 (05 2019) ISSN: 1476-5438 [Electronic] England
PMID30664714 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • CYFIP2 protein, human
Topics
  • Adaptor Proteins, Signal Transducing (genetics)
  • Child
  • Child, Preschool
  • Cytoplasm (metabolism)
  • Facies
  • Female
  • Humans
  • Infant
  • Intellectual Disability (genetics)
  • Male
  • Models, Molecular
  • Mutation (genetics)
  • Seizures (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: